Cytotoxic T lymphocytes (CTLs) eliminate virusinfected cells and tumor cells by two distinct killing pathways, mediated by lytic granules containing perforin and by Fas ligand (FasL). ECH [(2R,3R,4S)-2,3epoxy-4-hydroxy-5-hydroxymethyl-6-(1E)-propenyl-cyclohex-5-en-1-one] has been shown to inhibit FasLdependent apoptosis or the killing pathway in shortterm culture. However, since ECH exhibited cell toxicity in long-term culture, we attempted the synthesis of less toxic epoxycyclohexenone derivatives. In the present study, we found that RKTS-33 [(2R,3R,4S)-2,3-epoxy-4hydroxy-5-hydroxymethyl-cyclohex-5-en-1-one] has cell toxicity lower than ECH in long-term culture, and further investigated the inhibitory effect of RKTS-33 on CTL-mediated killing pathways. RKTS-33 did not affect cell-surface expression of FasL upon CD3 stimulation, but profoundly inhibited the FasL-dependent killing pathway mediated by CD4 þ and CD8 þ CTLs, indicating that RKTS-33 specifically blocks target cell apoptosis but not CTL function. By contrast, RKTS-33 did not affect the perforin-dependent killing pathway in CD8 þ CTLs. These results indicate that RKTS-33 is a specific inhibitor of the FasL-dependent killing pathway in CTL-mediated cytotoxicity.
mediated by lytic granules that contain the pore-forming protein perforin and serine proteases known as granzymes and by Fas ligand (FasL). 1, 2) Upon recognition of target cells via T cell receptor (TCR), CTLs rapidly release lytic granules into the interface between CTLs and target cells. 1, 2) Perforin facilitates translocation of granzymes A and B into the cytosol, leading to target cell apoptosis. 3) Granzyme B triggers caspase-dependent apoptosis, whereas granzyme A initiates caspaseindependent apoptosis. 4, 5) Upon TCR stimulation, CTLs are also induced to express FasL on the cell surface. 1, 2) Ligation of Fas by FasL induces recruitment of FADD and procaspase-8, resulting in the formation of the death-inducing signaling complex (DISC). 6, 7) In the DISC, procaspase-8 undergoes dimerization and subsequent self-cleavage, generating the active heterotetramer. Active caspase-8 cleaves downstream substrates such as procaspase-3 and the Bcl-2 family member Bid, leading to apoptosis execution.
Recently, we reported that an epoxycyclohexenone derivative [(2R,3R,4S)-2,3-epoxy-4-hydroxy-5-hydroxymethyl-6-(1E)-propenyle-cyclohex-5-en-1-one] (ECH; Fig. 1A ) blocks activation of procaspase-8 in the DISC and thereby inhibits death receptor-mediated apoptosis, while death receptor-independent apoptosis induced by chemicals and UV irradiation is totally insensitive to ECH. 8) Consistent with these findings, we have shown that ECH inhibits FasL-dependent apoptosis of target cells induced by CD4 þ and CD8 þ CTLs, but barely influences perforin-dependent DNA fragmentation and cytolysis of target cells mediated by CD8 þ CTLs. 9) These findings indicate that ECH is a specific inhibitor of the FasL-dependent CTL-mediated killing pathway. However, since ECH itself exhibited cell toxicity in y To whom correspondence should be addressed. Fax: +81-45-924-5832; E-mail: tkataoka@bio.titech.ac.jp Abbreviations: CMA, concanamycin A; CTLs, cytotoxic T lymphocytes; DISC, death-inducing signaling complex; DTAF, dichlorotriazinylaminofluorescein; ECH, (2R,3R,4S)-2,3-epoxy-4-hydroxy-5-hydroxymethyl-6-(1E)-propenyl-cyclohex-5-en-1-one; E:T, effector:target; FasL, Fas ligand; IC 50 , 50% inhibitory concentration; KLH, keyhole limpet hemocyanin; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; RKTS-33, (2R,3R,4S)-2,3-epoxy-4-hydroxy-5-hydroxymethyl-cyclohex-5-en-1-one; TCR, T cell receptor; TdR, thymidine long-term culture, ECH might be applicable only to the short-term killing assay.
A series of epoxycyclohexenone derivatives were asymmetrically synthesized via key synthetic intermediates obtained from lipase-catalyzed kinetic resolution. 10) RKTS-33 [(2R,3R,4S)-2,3-epoxy-4-hydroxy-5-hydroxymethyl-cyclohex-5-en-1-one] (Fig. 1A) has been found to inhibit FasL-induced apoptosis as almost effectively as ECH without any inhibitory effect on staurosporineinduced apoptosis in human leukemia cell lines. 10) In the present study, we found that RKTS-33 has cell toxicity lower than ECH in long-term culture, and further investigated the inhibitory effect of RKTS-33 on CTLmediated killing pathways.
Materials and Methods
Cells. CTL clones and target cells were kindly provided by Dr. N. Shinohara (Department of Immunology, Kitasato University School of Medicine, Kanagawa, Japan). The H-2 d -specific CD8 þ CTL clone OE4, 11) the keyhole limpet hemocyanin (KLH)-specific H-2 d (I-E d )-restricted CD4 þ CTL clone BK-1, 12) mouse B lymphoma A20, A20.HL, and A20.FO derived from BALB/c mice (H-2 d ), mouse thymic lymphoma L5178Y derived from DBA/2 mice (H-2 d ), and the Fas-expressing transfectant of L5178Y (L5178Y-Fas) 13) were maintained as described in our previous paper. 9) A20.HL cells were BALB/c B lymphoma transfected with light and heavy chain genes of anti-trinitrophenol IgM antibody. 14) A20.FO cells were the Fas-negative variant subcloned from Fas-positive A20.2J cells. 15) Reagents. RKTS-33 and ECH were synthesized as described previously. 10) Concanamycin A (CMA) and GM6001 were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan) and Calbiochem (San Diego, CA), respectively. Recombinant human soluble FasL 16) was a gift from Dr. J. Tschopp (Department of Biochemistry, University of Lausanne, Epalinges, Switzerland).
Cell viability assay. A20 cells were incubated with the indicated concentrations of RKTS-33 or ECH for 3 d and then pulsed with 500 mg/ml of 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide (MTT) (Sigma, St. Louis, MO) for 4 h in 96-well microtiter plates. MTTformazan was then solubilized with 5% SDS overnight, and A 595 was measured. Cell viability (%) was calculated as (experimental A 595 À background A 595 )/(control A 595 À background A 595 ) Â 100.
DNA fragmentation assay. Target cells were labeled with 37 kBq of [methyl-3 H] thymidine (TdR; ICN Biomedicals, Costa Mesa, CA) for 16 h and washed three times before use. [methyl-3 H]TdR-labeled cells (1 Â 10 5 cells/ml, 100 ml) were preincubated with the indicated concentrations of RKTS-33 or ECH and mixed with equal volumes of CTL suspension in round-bottom 96-well microtiter plates, followed by centrifugation (300 Â g, 3 min). The concentrations of RKTS-33 during 4 h coculture with CTLs was diluted to half the initial concentrations. At the end of culture, the cells were lysed by pipetting in the presence of 0.1% Triton X-100. After centrifugation (600 Â g, 5 min), the supernatants were harvested and measured for radioactivity. Specific 3 H-DNA release was calculated using the following formula: (experimental cpm À spontaneous cpm)/(maximum cpm À spontaneous cpm) Â 100.
Analysis of granule exocytosis. Granule exocytosis was analyzed as described in our previous paper. 9) Briefly, OE4 cells were incubated in 96-well microtiter plates coated with or without anti-mouse CD3 antibody 145-2C11. The granzyme A activity of the culture supernatants was measured using N -benzyloxycarbonyl-L-lysine thiobenzyl ester.
Analysis of FasL expression. Biotinylated anti-mouse
FasL antibody FLIM58 17) was kindly provided by Dr. T. Suda (Cancer Research Institute, Kanazawa University, Kanazawa, Japan). CTL clones (1 Â 10 6 cells) were stained with biotinylated FLIM58 for 45 min and then stained with dichlorotriazinylaminofluorescein (DTAF)streptavidin (Jackson Immunoresearch Laboratories, West Grove, PA) for 30 min followed by FACS analysis. 
Results

RKTS-33 is a less toxic epoxycyclohexenone derivative than ECH
Murine B lymphoma A20 cells were incubated with RKTS-33 or ECH for 3 d, and cell viability was measured by MTT assay (Fig. 1B) . ECH decreased cell viability in a dose-dependent manner, indicating that ECH has cell toxicity in long-term culture. As a less toxic epoxycylohexenone derivative, RKTS-33 exhibited 4-fold lower cell toxicity to A20 cells than did ECH.
RKTS-33 inhibits Fas-mediated apoptosis induced by soluble FasL
A20 cells undergo DNA fragmentation upon stimulation with cross-linked FasL, whereas Fas-negative A20.FO cells are insensitive to cross-linked FasL. 9) In FasL-treated A20 cells, RKTS-33 inhibited DNA fragmentation in a dose-dependent manner, almost completely at 100 mM ( Fig. 2A) . Murine thymic lymphoma L5178Y-Fas cells but not L5178Y cells are sensitive to cross-linked FasL. 9) FasL-induced DNA fragmentation in L5178Y-Fas cells was prevented by RKTS-33 in a dose-dependent manner, almost completely at 100 mM (Fig. 2B) .
RKTS-33 inhibits the FasL-dependent killing pathway mediated by CD4 þ CTLs
The KLH-specific CD4 þ CTL clone BK-1 cells are perforin-negative and kill target cells via the FasLdependent killing pathway. 13, 18) BK-1 cells are able to induce DNA fragmentation only when A20.HL cells are pulsed with KLH. Similarly to DNA fragmentation induced by soluble FasL, RKTS-33 inhibited FasLdependent DNA fragmentation mediated by BK-1 cells (Fig. 3 ).
RKTS-33 does not inhibit the perforin-dependent killing pathway mediated by CD8 þ CTLs
The H-2 d -specific CD8 þ CTL clone OE4 cells kill Fas-negative A20.FO cells and L5178Y cells only via the perforin-dependent killing pathway. RKTS-33 failed to affect DNA fragmentation induced by OE4 cells even when A20.FO cells and L5178Y cells were pretreated with 100 mM RKTS-33 ( Fig. 4A, B) .
RKTS-33 inhibits the FasL-dependent killing pathway mediated by CD8 þ CTLs
A20 cells and L5178Y-Fas cells express cell-surface Fas and are induced to undergo apoptosis by OE4 cells via both the perforin-dependent and the FasL-dependent killing pathways. Vacuolar type H þ -ATPase inhibitor CMA specifically blocks the perforin-dependent killing pathway. 15) Although RKTS-33 did not affect DNA fragmentation induced by OE4 cells without CMA pretreatment, FasL-dependent DNA fragmentation induced by CMA-treated OE4 cells was inhibited by RKTS-33 in a dose-dependent manner (Fig. 5A) , as observed with DNA fragmentation induced by soluble FasL (Fig. 2A) . In contrast to A20 cells, L5178Y-Fas cells are killed dominantly via the FasL-dependent pathway. 9) DNA fragmentation of L5178Y-Fas cells induced by nontreated and CMA-treated OE4 cells was dose-dependently inhibited by RKTS-33 ( Fig. 5B ).
RKTS-33 does not affect effector/target conjugate formation
To exclude the possibility that RKTS-33 influences CTL-target interaction, RKTS-33-pretreated A20 cells were mixed with OE4 cells, and the resulting conjugate formation was analyzed. RKTS-33 did not affect conjugate formation between OE4 cells and A20 cells even when A20 cells were pretreated with RKTS-33 at 100 mM (data not shown).
RKTS-33 partially affects granule exocytosis in CD8 þ CTLs
OE4 cells release lytic granules into the culture medium when incubated with plate-bound anti-TCR or anti-CD3 antibody. In contrast to coculture with target cells, CD3 stimulation can induce abundant release of granzyme A. In the present experimental system, RKTS-33 partially reduced CD3-induced granule exocytosis ( Fig. 6 ), but RKTS-33 barely affected the perforin-dependent killing pathway mediated by OE4 cells (Fig. 4) . These data suggest the possibility that excess amounts of lytic granules are exocytosed from CTLs to target cells and that a portion of the granular components (perforin and granzymes) is sufficient to induce target cell apoptosis. OE4 cells were incubated with ( ) or without ( ) immobilized anti-CD3 antibody in the presence of serial dilutions of RKTS-33 for 4 h. Culture supernatants were measured for granzyme A activity. The data points represent the mean AE SD of triplicate cultures.
RKTS-33 does not affect cell-surface FasL expression in CD4 þ and CD8 þ CTLs
TCR stimulation induces de novo synthesis and subsequent cell-surface expression of membrane-bound FasL. Membrane-bound FasL is converted to its soluble form by the action of metalloproteinase. 19) To investigate whether RKTS-33 inhibits cell-surface expression of FasL, OE4 cells and BK-1 cells were pretreated with RKTS-33 and stimulated with immobilized anti-CD3 antibody in the presence of the metalloproteinase inhibitor GM6001. CD3 stimulation led to strong induction of cell-surface FasL in OE4 cells and BK-1 cells, but RKTS-33 did not influence cell-surface FasL expression in these CTL clones (Fig. 7A, B) . By contrast, a 30% reduction in cell-surface FasL expression was observed when OE4 cells and BK-1 cells were treated with 50 mM ECH (data not shown).
Discussion
In the present study, we found that RKTS-33 is a less toxic epoxycyclohexenone derivative than ECH in longterm culture, and further investigated the inhibitory effect of RKTS-33 on two distinct CTL-mediated killing pathways. RKTS-33 did not influence CD3-induced expression of cell-surface FasL by CD4 þ and CD8 þ CTLs, but prevented FasL-induced target cell apoptosis mediated by soluble FasL as well as CD4 þ and CD8 þ CTLs. In contrast, the perforin-dependent killing pathway mediated by CD8 þ CTLs was insensitive to RKTS-33. Thus our present results indicate that RKTS-33 is a specific inhibitor of the FasL-dependent killing pathway in CTL-mediated cytotoxicity.
Recently, we have shown that ECH inhibits selfactivation of procaspase-8 in the DISC and specifically prevents death receptor-mediated apoptosis. 8) Furthermore, ECH inhibits the FasL-dependent killing pathway but not the perforin-dependent killing pathway in CTLmediated cytotoxicity. 9) RKTS-33 is an ECH derivative devoid of a propenyl group at C-6. 10) RKTS-33 has been shown to inhibit FasL-dependent apoptosis but not staurosporine-induced apoptosis in human leukemia cell lines. 10) Because of the structural similarity between ECH and RKTS-33, it appears likely that RKTS-33 inhibits activation of procaspase-8 in the cell. Consistent with this, we have observed that RKTS-33 specifically inhibits the FasL-dependent killing pathway but not the perforin-dependent killing pathway in CTL-mediated cytotoxicity. Moreover, RKTS-33 did not affect expression of cell-surface FasL on CTLs, indicating that RKTS-33 specifically blocks target cell apoptosis in the CTL-mediated killing pathway.
Treatment of cultured cell lines with a general peptidebased caspase inhibitor, zVAD-fmk, efficiently blocks activation of procaspase-8 upon Fas stimulation, but does not affect their proliferative responses. The observation that ECH and RKTS-33 reduce cell viability in long-term culture suggests that these compounds have additional target molecules essential for cell cycle progression. The length of the side chain at C-6 might be important for binding to target molecules, since RKTS-33 is less toxic than ECH, and RKTS-35, which possesses a bulky phenyl group at C-6, shows stronger toxicity than ECH without any inhibition on Fas-dependent apoptosis. 10) The IC 50 values of RKTS-33 in FasL-dependent apoptosis mediated by soluble FasL and CTLs were 1.2to 2-fold higher than those of ECH (Table 1) , whereas the inhibitory concentration of RKTS-33 on the longterm proliferation of A20 cells was 4-fold higher than that of ECH. The molecular mechanism of the antiproliferative activity of RKTS-33 and ECH has yet to be determined. RKTS-33 did not induce apoptosis in shortterm culture in various tumor cell lines and showed weaker toxic activity than ECH in long-term culture. Therefore RKTS-33 might be a useful bioprobe that specifically blocks the FasL-dependent CTL-mediated killing pathway. 
